Clinical Trial Update: A Clinical Trial Evaluating the Safety of Combining Lutathera(R) and Azedra(R) to Treat Mid-gut Neuroendocrine Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes that the Phase 1/2 study evaluating the safety of combining Lutathera and Azedra for midgut gastroenteropancreatic neuroendocri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteropancreatic Neuroendocrine Tumors
• Midgut Neuroendocrine Tumor

Drugs mentioned

• Azedra (iobenguane I-131)
• LUTATHERA (Lutetium Lu-177 dotatate)

Snippet

Sponsor: David Bushnell | Conditions: Gastro-enteropancreatic Neuroendocrine Tumor, Neuroendocrine Tumors | Phase 1, Phase 2 | Status: WITHDRAWN